Retrospective Side Effect Profiling of the Metastatic Melanoma Combination Therapy Ipilimumab-Nivolumab Using Adverse Event Data

Retrospective Side Effect Profiling of the Metastatic Melanoma Combination Therapy Ipilimumab-Nivolumab Using Adverse Event Data

Recent studies suggest that combining nivolumab with ipilimumab is a more effective treatment for melanoma patients, compared to using ipilimumab or nivolumab alone. However, treatment with these immunotherapeutic agents is frequently associated with increased risk of toxicity, and (auto-) immune-re...

Full description

Bibliographic Details
Main Authors: Theodoros G. Soldatos, Antonia Dimitrakopoulou-Strauss, Lionel Larribere, Jessica C. Hassel, Christos Sachpekidis
Format: Article
Language:English
Published: MDPI AG 2018-10-01
Series:Diagnostics
Subjects:
side effects
ipilimumab
nivolumab
melanoma
real world data
data mining
pharmacoepidemiology
proportional reporting ratio
Online Access:https://www.mdpi.com/2075-4418/8/4/76

Internet

https://www.mdpi.com/2075-4418/8/4/76

Similar Items